Literature DB >> 31624387

Comparative clinical study on seldom segment with multiple segment intramedullary primary spinal cord tumors.

J J Sun1, J Yang1, J C Xie1, Q Chang2, C C Ma1, M Zheng3, H I Liao4, T Wang1, X D Chen1, Y F Han1, G Z Lin1, T Yu1, J Zhang1, Y Si1.   

Abstract

OBJECTIVE: Several clinical studies were performed on multi-segment intramedullary primary spinal cord tumors. However, no clinical study focused on the relationship between different vertebral segments intramedullary tumors involvement and neurological functions, as well as prognosis of the patients. This prospective study was performed to compare clinical analysis on neurological functions and prognosis of the patients with intramedullary spinal cord primary tumors.
METHODS: A prospective cohort study was performed in a single medical center, Neurosurgical Department, Peking University Third Hospital. Between Jan. 1, 2010 and Dec. 30, 2015, 135 patients underwent microsurgery for intramedullary primary spinal cord tumors. The intramedullary tumor length occupying 3 or more vertebral body levels was considered as multiple segments intramedullary primary spinal cord tumor, and occupying one or two vertebral body levels considered as seldom segments. Preoperative and postoperative functions were assessed using IJOA (improved Japanese orthopaedic association) scoring system, and analyzed using the appropriate statistical tests.
RESULTS: Among the 135 patients, 52 cases had seldom segments intramedullary primary spinal cord tumors, and 83 cases had multiple segments. In the seldom group, 32 (62%) patients presented with normal urine and stool function, 8 (15%) patients with severe dysfunction, 7 (14%) with slight dysfunction, and 5 (9%) with incontinence, and 30 (58%) patients demonstrated various degrees of limbs weakness. The preoperative IJOA scores of the patients were 16.9±2.4. The postoperative IJOA scores at the end of 3 months were 16.6±2.3. The current IJOA scores until the end of the follow-up were 17.5±4.4. In the multiple group, 37 (45%) patients presented with normal urine and stool functions, 26 (31%) patients with slight dysfunction, 11 (13%) with severe dysfunction, and 9 (11%) with incontinence, and 62 (75%) patients demonstrated various degrees of limbs weakness. The preoperative IJOA scores of the patients were 15.6±3.4. The postoperative IJOA scores at the end of 3 months were 15.5±3.8. The current IJOA scores until the end of the follow-up were 16.9±5.8. The difference of presenting urine and stool dysfunction (Z=-1.35, P=0.18) was not statistically significant between the different patient groups. However, the difference of presenting limbs weakness (Z=-2.06, P=0.04) was statistically significant between the two groups. Most patients with multiple segment intramedullary tumors suffered from various limbs weakness. The difference of the preoperative IJOA score (P=0.02) and the postoperative early IJOA score (P=0.004) of the patients was statistically significant between the seldom and multiple segments groups. Preoperative and early postoperative neurological function of the patients was better with seldom segments tumor than with multiple segments tumor. Most patients with multi-segment intramedullary tumors experienced various limbs weakness. However, the difference of long-term neurological function (P=0.12) between the seldom and multiple segments groups was not statistically significant. The neurological function of the patients with multiple segments intramedullary tumor was remarkably improved after physical therapy.
CONCLUSION: Perioperative neurological function of the patients with seldom segments primary tumor was superior to that of the patients with multiple segments primary tumor, especially for limb strength. The neurological function of the patients with multiple segments intramedullary primary tumor was remarkably improved after physical therapy during long-term follow-up.

Entities:  

Mesh:

Year:  2019        PMID: 31624387      PMCID: PMC7433534     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  22 in total

Review 1.  Ten years' experience in the management of spinal intramedullary tumors in a single institution.

Authors:  Sumit Bansal; Pankaj Ailawadhi; Ashish Suri; Shashank Sharad Kale; P Sarat Chandra; Manmohan Singh; Rajender Kumar; Bhawani S Sharma; Ashok Kumar Mahapatra; Mehar C Sharma; Chitra Sarkar; Pramod Bithal; Hari Har Dash; Sailesh Gaikwad; Nalin Kumar Mishra
Journal:  J Clin Neurosci       Date:  2012-12-28       Impact factor: 1.961

2.  Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.

Authors:  Bedjan Behmanesh; Matthias Setzer; Juergen Konczalla; Patrick Harter; Johanna Quick-Weller; Lioba Imoehl; Kea Franz; Florian Gessler; Volker Seifert; Gerhard Marquardt
Journal:  World Neurosurg       Date:  2016-10-21       Impact factor: 2.104

3.  Fluorescein-Guided Resection of Intramedullary Spinal Cord Tumors: Results from a Preliminary, Multicentric, Retrospective Study.

Authors:  Francesco Acerbi; Claudio Cavallo; Karl-Michael Schebesch; Mehmet Osman Akçakaya; Camilla de Laurentis; Mustafa Kemal Hamamcioglu; Morgan Broggi; Alexander Brawanski; Jacopo Falco; Roberto Cordella; Paolo Ferroli; Talat Kiris; Julius Höhne
Journal:  World Neurosurg       Date:  2017-09-19       Impact factor: 2.104

4.  Intramedullary low-grade astrocytomas: long-term outcome following radical surgery.

Authors:  G I Jallo; S Danish; L Velasquez; F Epstein
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

5.  Outcome predictors in the management of spinal cord ependymoma.

Authors:  D Gavin Quigley; Naeem Farooqi; Timothy J D Pigott; Gordon F G Findlay; Robin Pillay; Neil Buxton; Michael D Jenkinson
Journal:  Eur Spine J       Date:  2006-07-25       Impact factor: 3.134

6.  Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.

Authors:  Mohamad H Fakhreddine; Anita Mahajan; Marta Penas-Prado; Jeffrey Weinberg; Ian E McCutcheon; Vinay Puduvalli; Paul D Brown
Journal:  Neuro Oncol       Date:  2013-01-14       Impact factor: 12.300

7.  Management of intramedullary spinal cord lesions: interdependence of the longitudinal extension of the lesion and the functional outcome.

Authors:  Florian H Ebner; Florian Roser; Markus Falk; Sabine Hermann; Juergen Honegger; Marcos Tatagiba
Journal:  Eur Spine J       Date:  2009-12-20       Impact factor: 3.134

8.  Progression free survival and functional outcome after surgical resection of intramedullary ependymomas.

Authors:  Kalil G Abdullah; Daniel Lubelski; Jacob Miller; Michael P Steinmetz; John H Shin; Ajit Krishnaney; Thomas E Mroz; Edward C Benzel
Journal:  J Clin Neurosci       Date:  2015-07-30       Impact factor: 1.961

9.  Surgical treatment of one hundred seventy-four intramedullary spinal cord tumors.

Authors:  Shuyuan Yang; Xinyu Yang; Guoliang Hong
Journal:  Spine (Phila Pa 1976)       Date:  2009-11-15       Impact factor: 3.468

10.  Microsurgical treatment and functional outcomes of multi-segment intramedullary spinal cord tumors.

Authors:  Jianjun Sun; Zhenyu Wang; Zhendong Li; Bin Liu
Journal:  J Clin Neurosci       Date:  2009-03-19       Impact factor: 1.961

View more
  1 in total

1.  Diagnostic Value of Emission Computed Tomography Combined with Computed Tomography for Metastatic Malignant Tumor of Spine.

Authors:  Feng Qin; Yapei Feng; Panpan Zhang; Yuemei Li; Weiqiang Fan
Journal:  Contrast Media Mol Imaging       Date:  2022-05-26       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.